2 Bridge going global with Start2Export2Canada
In the context of international business development and expansion, 2 Bridge and Denys Research Consultants (DRC) are participating in Start2Export2Canada, an international trade mission to Canada.
This business trip to Montreal-Drummondville-Quebec is part of a coaching programme organized by Flanders Investment and Trade and VOKA, coaching entrepeneurs on how to establish business on the Canadian market.
Strategic collaboration between 2 Bridge and Denys Research Consultants
2 Bridge and Denys Research Consultants are proud to announce a strategic collaboration to provide fully integrated solutions in clinical and healthcare product development. The combined strength of our services go from drug development strategy over due diligence and opportunity scouting to full clinical trial services in project management and monitoring for Phase I through Phase IV clinical trials. Our customer portfolio ranges from the academic research over small and medium-sized biotech and medical device companies to large pharmaceutical enterprises.
2 Bridge is attending the Cell & Gene Therapy Manufacturing Conference
Our colleague Geertje Van Beeck (Managing Partner) is attending Europe’s most comprehensive advanced therapies manufacturing conference, the Cell & Gene Therapy Manufacturing Conference in London, on Sept 7-8, 2016.
2 Bridge is attending the Vlerick Healthcare Conference
Our colleagues Ann Meulemans (CEO & Managing Partner) and Leen Thielemans (Managing Partner) are attending the Vlerick Healthcare Conference in Brussels on Oct 27, 2016.
Our 2 Bridge team keeps growing
We are very excited to announce that within the past 1,5 year, 2 Bridge has welcomed 4 new team members:
An Rykx (clinical project leader)
Leni Vandekerckhove (scientific project manager)
Fiona Cilli (clinical program leader)
Inge Verachtert (CMC project manager)
2 Bridge is certified for KMO-portefeuille to provide training for the next 5 years
2 Bridge is certified to organise training activities on drug development and product purity management for the next 5 years. More specific information can be found on the Training tab in our main menu. If you have any questions or needs on training, please feel free to contact us.
2Bridge will be present at Janssen Pharmaceutica’s pitching event
In the context of Janssen’s 11th Entrepreneurial Innovation Boot Camp, 7 promising ventures will present their business plan on the Open Life Sciences Campus in Beerse, at December, 5th.
These ventures, a mix of university spin-offs, a Janssen spin-off and young companies, focus on assistive technology development, research platforms or drug discovery and development platforms.
Webinar on Extractables & Leachabes
Free webinar in cooperation with Analytical Services – “Threshold concepts and best practice recommendations for toxicological assessment”, presented by Dr. Koen Van Deun (European Registered Toxicologist). Scientifically justified safety thresholds for Leachables & Extractables were developed for Orally Inhaled and Nasal Drug products (OINDPs) and Parenteral and Ophthalmic Drug Products (PODP). These thresholds allow to do a step-wise analysis and assessment of Leachables & Extractables according to their hazard potential.
2Bridge joined FlandersBio
FlandersBio is the networking organisation for the Life Sciences sector in Flanders, a dynamic non-profit, fee-based organisation with currently more than 270 members.
We are pleased to announce that 2 Bridge has become part of FlandersBio’s membership list.
2Bridge is certified for KMO Portefeuille to provide training
2Bridge is planning to organise training activities on drug development and product purity management in cooperation with Partner organisations. More specific information will follow soon. If you have any questions or needs on training, please feel free to contact us.